Follow the PHARMANUTRA CS share price and the full insider trade history of the company, a listed equity based in Italy. Shares are quoted on IT IT, under the oversight of Consob. Operating in the Health Care sector, PHARMANUTRA CS has logged 1 public disclosures. Market capitalisation: €861.8m. The latest transaction was reported on 24 July 2024 (Other). Among the most active insiders: Unknown. All data is accessible without an account.
Analysts rate PHARMANUTRA CS Strong Buy (bullish), based on 3 analysts. Average price target: €81.33.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.